NorthWest Biotherapeutics Inc (NWBO)

[LearningEveryTrade]

You said

yeah FDA will like that

There is also some possibility that changes requested by the FDA and/or other regulators could complicate the application process for product approval

Then, later...

FDA lifts the partial clinical hold on PIII trial. With Northwest Bio having decided to close enrollment 17 subjects short of its target, the lifting of the partial clinical hold will not trigger renewed recruitment in the trial. But the FDA action clears a regulatory concern for Northwest Bio.

Ladies and gentlemen, place your bets... final score is NWBO 1, Sealions 0. A close, back and forth game... two winners, the patients and the patient shareholders.